Table 1.
Demographic information and symptom prevalence.
VSS patients ( n = 125) | ||
---|---|---|
Number | Percentage | |
Age (mean, SD) | 31.3, 10.4 | – |
Female (male) | 63 (62) | 50.4% (49.6%) |
Lifelong VSS | 45 | 36% |
Later onset VSS: | 80 | 64% |
Age of onset (mean, SD) | 22.4, 9.8 | – |
VSS duration (mean, SD) | 9.7, 9.9 | – |
VSS intensity (mean, SD) | 3.7, 1.3 | – |
VSS disruptiveness (mean, SD) | 3.6, 1.6 | – |
VSS impact on quality of life (mean, SD) | 3.7, 1.7 | – |
Migraine | 61 | 48.8% |
Family history of migraine | 66 | 52.8% |
Relative with VSS | 5 | 4% |
Visual symptoms | ||
Palinopsia: afterimages | 108 | 86.4% |
Palinopsia: trailing | 66 | 52.8% |
Nyctalopia | 88 | 70.4% |
Photophobia | 58 | 46.4% |
Floaters | 113 | 90.4% |
Blue field entoptic phenomena | 91 | 72.8% |
Halos | 83 | 66.4% |
Number of visual symptoms (mean, SD) | 5.4, 1.8 | – |
Non-visual sensory symptoms | ||
Tinnitus | 97 | 77.6% |
Tremor | 43 | 34.4% |
Paraesthesia | 59 | 47.2% |
Dizziness | 44 | 35.2% |
Other symptoms | ||
Neck pain | 63 | 50.4% |
Irritability | 70 | 56% |
Concentration problems | 99 | 79.2% |
Depersonalisation | 45 | 44.1% |
Derealization | 31 | 30.4% |
Previous or current anxiety disorder | 56 | 44.8% |
Previous or current depressive disorder | 48 | 38.4% |